Veradigm | MDRX - Passivo Circulante

Preço das Ações
4.21
Mudança Diária
-0.10 -2.32%
Mensal
-9.46%
Anual
-0.94%
Q2 Previsão
4.12




Passivo Circulante Alterar Data
Alcidion AUD 22.33M 1.47M 2025-12
Ambu A/S DKK 1.07B 94M 2025-12
Amplifon EUR 725.71M 389.21M 2025-09
Cardinal Health USD 43.31B 3.05B 2025-12
Centene USD 36.7B 3.93B 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Cigna USD 56.34B 111M 2025-12
Coloplast 7.93B 1.42B 2025-12
Computer Programs Systems USD 57.96M 4.21M 2025-12
Convatec Group USD 512.3M 130.7M 2024-12
CVS Health USD 88.69B 4B 2025-12
Diasorin EUR 555.45M 289.08M 2025-06
Elevance Health USD 41.04B 157M 2025-12
General Electric Aerospace USD 38.98B 1.78B 2025-12
Gulf Medical Proj AED 171.09M 18.53M 2025-12
Humana USD 16.35B 166M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Maximus USD 608.05M 157.12M 2025-12
McKesson USD 68.13B 100M 2025-12
Med Life RON 883.35M 20.56M 2025-12
Molina Healthcare USD 7.37B 109M 2025-12
Omnicell USD 476.61M 20.02M 2025-12
Oriola-kd EUR 790.1M 39.5M 2025-12
Owens Minor USD 947.08M 1.52B 2025-12
Quest Diagnostics USD 2.28B 144M 2025-12
Rede D'or Sao Luiz BRL 19.27B 602.18M 2025-12
Siemens Healthineers EUR 13.65B 1.01B 2025-12
Sonova Holding CHF 1.5B 303M 2025-06
Supermax Corporation Bhd MYR 320.12M 36K 2025-12
UnitedHealth USD 115.53B 4.74B 2025-09
Veeva Systems USD 1.64B 692.18M 2025-12
Veradigm USD 230.31M 22.78M 2022-12
Xerox USD 3.4B 973M 2025-09